{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper indicates that LRRK2 mutations (e.g., R1441G, Y1699C, G2019S) decrease homeostatic phosphorylation of S935 and impair 14-3-3 binding, which are critical for LRRK2 function and PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper directly links LRRK2 mutations to impaired phosphorylation and 14-3-3 binding, which are key to LRRK2-mediated cellular functions and PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro and cell culture experiments to demonstrate phosphorylation and binding effects, which are standard assays for protein function analysis.",
          "judgment": "Yes",
          "reasoning": "The assays (e.g., phosphorylation analysis, 14-3-3 binding assays) are widely used to evaluate protein function and are relevant to LRRK2's role in PD."
        },
        {
          "step_name": "Step 3: Validity of specific assays",
          "extracted_paper_info": "The study includes controls (wild-type vs. mutant LRRK2) and multiple replicates, with clear effects on phosphorylation and 14-3-3 binding.",
          "judgment": "Yes",
          "reasoning": "The experiments include variant controls (mutant LRRK2) and replicates, with measurable functional impairments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutations significantly reduce phosphorylation of S935 and 14-3-3 binding, which are critical for LRRK2 function, leading to strong functional evidence.",
          "judgment": "Yes",
          "reasoning": "The mutations directly impair key functional interactions (phosphorylation, 14-3-3 binding), which are central to LRRK2's role in PD pathogenesis."
        }
      ],
      "overall_strength": "PS3_very_strong"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper indicates that LRRK2 mutations (e.g., R1441G, Y1699C, G2019S) decrease homeostatic phosphorylation of S935 and impair 14-3-3 binding, which are critical for LRRK2 function and PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper directly links LRRK2 mutations to impaired phosphorylation and 14-3-3 binding, which are key to LRRK2-mediated cellular functions and PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro and cell culture experiments to demonstrate phosphorylation and binding effects, which are standard assays for protein function analysis.",
          "judgment": "Yes",
          "reasoning": "The assays (e.g., phosphorylation analysis, 14-3-3 binding assays) are widely used to evaluate protein function and are relevant to LRRK2's role in PD."
        },
        {
          "step_name": "Step 3: Validity of specific assays",
          "extracted_paper_info": "The study includes controls (wild-type vs. mutant LRRK2) and multiple replicates, with clear effects on phosphorylation and 14-3-3 binding.",
          "judgment": "Yes",
          "reasoning": "The experiments include variant controls (mutant LRRK2) and replicates, with measurable functional impairments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutations significantly reduce phosphorylation of S935 and 14-3-3 binding, which are critical for LRRK2 function, leading to strong functional evidence.",
          "judgment": "Yes",
          "reasoning": "The mutations directly impair key functional interactions (phosphorylation, 14-3-3 binding), which are central to LRRK2's role in PD pathogenesis."
        }
      ],
      "overall_strength": "PS3_very_strong"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper indicates that LRRK2 mutations (e.g., R1441G, Y1699C, G2019S) decrease homeostatic phosphorylation of S935 and impair 14-3-3 binding, which are critical for LRRK2 function and PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper directly links LRRK2 mutations to impaired phosphorylation and 14-3-3 binding, which are key to LRRK2-mediated cellular functions and PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro and cell culture experiments to demonstrate phosphorylation and binding effects, which are standard assays for protein function analysis.",
          "judgment": "Yes",
          "reasoning": "The assays (e.g., phosphorylation analysis, 14-3-3 binding assays) are widely used to evaluate protein function and are relevant to LRRK2's role in PD."
        },
        {
          "step_name": "Step 3: Validity of specific assays",
          "extracted_paper_info": "The study includes controls (wild-type vs. mutant LRRK2) and multiple replicates, with clear effects on phosphorylation and 14-3-3 binding.",
          "judgment": "Yes",
          "reasoning": "The experiments include variant controls (mutant LRRK2) and replicates, with measurable functional impairments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutations significantly reduce phosphorylation of S935 and 14-3-3 binding, which are critical for LRRK2 function, leading to strong functional evidence.",
          "judgment": "Yes",
          "reasoning": "The mutations directly impair key functional interactions (phosphorylation, 14-3-3 binding), which are central to LRRK2's role in PD pathogenesis."
        }
      ],
      "overall_strength": "PS3_very_strong"
    }
  ]
}